• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Prenatal DNA Sequencing for Fetal Aneuploidy Also Detects Maternal Cancer: Importance of Timely Workup and Management in Pregnant Women.

作者信息

Turriff Amy E, Annunziata Christina M, Bianchi Diana W

机构信息

Prenatal Genomics & Therapy Section, Center for Precision Health Research, National Human Genome Research Institute, National Institutes of Health (NIH), Bethesda, MD.

Women's Malignancies Branch, National Cancer Institute, NIH, Bethesda, MD.

出版信息

J Clin Oncol. 2022 Aug 1;40(22):2398-2401. doi: 10.1200/JCO.22.00733. Epub 2022 Jun 15.

DOI:10.1200/JCO.22.00733
PMID:35704839
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9467676/
Abstract
摘要

相似文献

1
Prenatal DNA Sequencing for Fetal Aneuploidy Also Detects Maternal Cancer: Importance of Timely Workup and Management in Pregnant Women.用于胎儿非整倍体检测的产前DNA测序也能检测出母体癌症：对孕妇进行及时检查和管理的重要性。
J Clin Oncol. 2022 Aug 1;40(22):2398-2401. doi: 10.1200/JCO.22.00733. Epub 2022 Jun 15.
2
Noninvasive Prenatal Testing and Incidental Detection of Occult Maternal Malignancies.非侵入性产前检测与隐匿性母体恶性肿瘤的意外发现。
JAMA. 2015 Jul 14;314(2):162-9. doi: 10.1001/jama.2015.7120.
3
Prenatal screening for fetal aneuploidy in singleton pregnancies.单胎妊娠胎儿非整倍体的产前筛查。
J Obstet Gynaecol Can. 2011 Jul;33(7):736-750. doi: 10.1016/S1701-2163(16)34961-1.
4
Sequencing shorter cfDNA fragments improves the fetal DNA fraction in noninvasive prenatal testing.短 cfDNA 片段测序可提高无创产前检测中胎儿 DNA 比例。
Am J Obstet Gynecol. 2019 Oct;221(4):345.e1-345.e11. doi: 10.1016/j.ajog.2019.05.023. Epub 2019 May 21.
5
Society for Maternal-Fetal Medicine Consult Series #57: Evaluation and management of isolated soft ultrasound markers for aneuploidy in the second trimester: (Replaces Consults #10, Single umbilical artery, October 2010; #16, Isolated echogenic bowel diagnosed on second-trimester ultrasound, August 2011; #17, Evaluation and management of isolated renal pelviectasis on second-trimester ultrasound, December 2011; #25, Isolated fetal choroid plexus cysts, April 2013; #27, Isolated echogenic intracardiac focus, August 2013).母胎医学会咨询系列第 57 号：中孕期单纯性软指标超声标记物用于染色体非整倍体的评估与管理：（取代咨询 10 号：单脐动脉，2010 年 10 月；咨询 16 号：中孕期超声诊断孤立性肠回声增强，2011 年 8 月；咨询 17 号：中孕期超声检查孤立性肾盂扩张的评估与管理，2011 年 12 月；咨询 25 号：孤立性胎儿脉络丛囊肿，2013 年 4 月；咨询 27 号：孤立性心内强回声灶，2013 年 8 月）。
Am J Obstet Gynecol. 2021 Oct;225(4):B2-B15. doi: 10.1016/j.ajog.2021.06.079. Epub 2021 Jun 23.
6
Prospective chromosome analysis of 3429 amniocentesis samples in China using copy number variation sequencing.使用拷贝数变异测序对中国 3429 例羊水穿刺样本进行前瞻性染色体分析。
Am J Obstet Gynecol. 2018 Sep;219(3):287.e1-287.e18. doi: 10.1016/j.ajog.2018.05.030. Epub 2018 May 29.
7
DNA sequencing versus standard prenatal aneuploidy screening.DNA 测序与标准产前非整倍体筛查。
N Engl J Med. 2014 Feb 27;370(9):799-808. doi: 10.1056/NEJMoa1311037.
8
Detection of fetal sex chromosome aneuploidy by massively parallel sequencing of maternal plasma DNA: initial experience in a Chinese hospital.通过对孕妇血浆DNA进行大规模平行测序检测胎儿性染色体非整倍体：一家中国医院的初步经验。
Ultrasound Obstet Gynecol. 2014 Jul;44(1):17-24. doi: 10.1002/uog.13361.
9
[Detection of fetal chromosomal aneuploidy in pregnant women at advanced maternal age during the first trimester].孕早期高龄孕妇胎儿染色体非整倍体的检测
Nan Fang Yi Ke Da Xue Xue Bao. 2014 May;34(5):655-8.
10
Clinical Practice Guidelines for Prenatal Aneuploidy Screening and Diagnostic Testing from Korean Society of Maternal-Fetal Medicine: (1) Prenatal Aneuploidy Screening.韩国母胎医学会产前非整倍体筛查和诊断检测临床实践指南：（1）产前非整倍体筛查。
J Korean Med Sci. 2021 Jan 25;36(4):e27. doi: 10.3346/jkms.2021.36.e27.

引用本文的文献

1
Incidental Diagnosis of Occult Maternal Malignancy With Routine Noninvasive Prenatal Testing During Pregnancy.孕期通过常规无创产前检测偶然诊断出隐匿性母体恶性肿瘤
Cureus. 2024 Dec 24;16(12):e76331. doi: 10.7759/cureus.76331. eCollection 2024 Dec.
2
Comparing the Introduction and Implementation of Noninvasive Prenatal Testing (NIPT) in Japan, the Netherlands, and the United States: An Integrative Review.日本、荷兰和美国无创产前检测（NIPT）的引入与实施比较：一项综合综述
Prenat Diagn. 2025 Jan 15. doi: 10.1002/pd.6708.
3
Prenatal cfDNA Sequencing and Incidental Detection of Maternal Cancer.产前游离DNA测序与孕妇癌症的偶然发现
N Engl J Med. 2024 Dec 5;391(22):2123-2132. doi: 10.1056/NEJMoa2401029.
4
Patients' perspectives on prenatal screening results that suggest maternal cancer: A qualitative analysis.患者对提示母体癌症的产前筛查结果的看法：定性分析。
Prenat Diagn. 2023 Aug;43(9):1101-1109. doi: 10.1002/pd.6406. Epub 2023 Jul 21.
5
Noninvasive Prenatal Testing Using Circulating DNA and RNA: Advances, Challenges, and Possibilities.利用循环 DNA 和 RNA 的无创性产前检测：进展、挑战和可能性。
Annu Rev Biomed Data Sci. 2023 Aug 10;6:397-418. doi: 10.1146/annurev-biodatasci-020722-094144. Epub 2023 May 17.
6
Patient attitudes and preferences about expanded noninvasive prenatal testing.患者对扩展的非侵入性产前检测的态度和偏好。
Front Genet. 2023 Apr 18;14:976051. doi: 10.3389/fgene.2023.976051. eCollection 2023.

本文引用的文献

1
Noninvasive Prenatal Test Results Indicative of Maternal Malignancies: A Nationwide Genetic and Clinical Follow-Up Study.提示母体恶性肿瘤的无创性产前检测结果：全国性遗传和临床随访研究。
J Clin Oncol. 2022 Aug 1;40(22):2426-2435. doi: 10.1200/JCO.21.02260. Epub 2022 Apr 8.
2
Cancer Diagnoses Following Abnormal Noninvasive Prenatal Testing: A Case Series, Literature Review, and Proposed Management Model.异常无创产前检测后的癌症诊断：病例系列、文献综述及建议的管理模式
JCO Precis Oncol. 2021 Nov;5:1001-1012. doi: 10.1200/PO.20.00429.
3
Comprehensive genome-wide analysis of routine non-invasive test data allows cancer prediction: A single-center retrospective analysis of over 85,000 pregnancies.对常规非侵入性检测数据进行全基因组综合分析可实现癌症预测：一项对超过85000例妊娠的单中心回顾性分析。
EClinicalMedicine. 2021 May 13;35:100856. doi: 10.1016/j.eclinm.2021.100856. eCollection 2021 May.
4
Management of pregnancy in women with cancer.癌症患者的妊娠管理。
Int J Gynecol Cancer. 2021 Mar;31(3):314-322. doi: 10.1136/ijgc-2020-001776.
5
Pregnancy and Cancer: the INCIP Project.妊娠与癌症：INCIP项目
Curr Oncol Rep. 2020 Feb 5;22(2):17. doi: 10.1007/s11912-020-0862-7.
6
Identifying occult maternal malignancies from 1.93 million pregnant women undergoing noninvasive prenatal screening tests.从 193 万例接受无创产前筛查检测的孕妇中识别隐匿性母体恶性肿瘤。
Genet Med. 2019 Oct;21(10):2293-2302. doi: 10.1038/s41436-019-0510-5. Epub 2019 Apr 12.
7
Current Controversies in Prenatal Diagnosis 2: NIPT results suggesting maternal cancer should always be disclosed.产前诊断的当前争议2：无创产前检测（NIPT）结果提示母体癌症时应始终予以披露。
Prenat Diagn. 2019 Apr;39(5):339-343. doi: 10.1002/pd.5379. Epub 2018 Dec 10.
8
Application of Cell-free DNA Analysis to Cancer Treatment.游离DNA分析在癌症治疗中的应用。
N Engl J Med. 2018 Nov 1;379(18):1754-1765. doi: 10.1056/NEJMra1706174.
9
Sequencing of Circulating Cell-free DNA during Pregnancy.孕期循环游离 DNA 测序。
N Engl J Med. 2018 Aug 2;379(5):464-473. doi: 10.1056/NEJMra1705345.
10
Unusual Prenatal Genomic Results Provide Proof-of-Principle of the Liquid Biopsy for Cancer Screening.异常的产前基因组结果为癌症筛查的液体活检提供了原理验证。
Clin Chem. 2018 Feb;64(2):254-256. doi: 10.1373/clinchem.2017.282459. Epub 2017 Dec 13.